TREM1 Antikörper

Produktnummer ABIN2192226

Produktdetails anti-TREM1 Antikörper

Target: TREM1 (Triggering Receptor Expressed On Myeloid Cells 1 (TREM1))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser TREM1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Flow Cytometry (FACS), Functional Studies (Func), Immunoassay (IA)

Sterilität: 0.2 μm filtered

Klon: 6B1

Anwendungsinformationen

Applikationshinweise: It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user's experimental setting. Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS, containing 0.1 % bovine serum albumin.

Lagerung: 4 °C

Informationen zur Lagerung: Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

Haltbarkeit: 12 months

Referenzen für anti-TREM1 Antikörper (ABIN2192226)

Radsak, Taube, Haselmayer, Tenzer, Salih, Wiewrodt, Buhl, Schild: "Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease." in: Clinical & developmental immunology, Vol. 2007, pp. 52040, (2008) (PubMed).

Haselmayer, Grosse-Hovest, von Landenberg, Schild, Radsak: "TREM-1 ligand expression on platelets enhances neutrophil activation." in: Blood, Vol. 110, Issue 3, pp. 1029-35, (2007) (PubMed).

Details zu TREM1

Target: TREM1 (Triggering Receptor Expressed On Myeloid Cells 1 (TREM1))

Andere Bezeichnung: Triggering Receptor Expressed On Myeloid Cells 1 (TREM1 Produkte)

Synonyme: TREM1 antikoerper, CD354 antikoerper, TREM-1 antikoerper, triggering receptor expressed on myeloid cells 1 antikoerper, TREM1 antikoerper, Trem1 antikoerper, LOC100349504 antikoerper

Hintergrund: (TREM-1). TREM-1 is a transmembrane glycoprotein belonging to a family related to the natural killer cell receptors. TREM-1 is an important activating receptor, of 26 kDa, involved in the innate inflammatory response and in sepsis. TREM-1 is expressed at low levels in the early development of the hematopoietic system and in the promonoistic stage and at high levels on neutrophil granulocytes (PMN), monocytes, and macrophage subsets. The expression of TREM-1 is upregulated by microbial products, that is, by toll-like receptor ligands such as lipoteichoic acid (LTA) of Gram-positive or lipopolysaccharide (LPS) of Gram-negative bacteria. Ligation of TREM-1 is synergistic with TLR agonists on the activation of receptor bearing cells. Platelets express a natural ligand for TREM-1. Receptor ligation activates the full repertoire of effector functions. TREM-1 is also produced in a soluble form (sTREM-1) of 17 kDa which is released in humans after endotoxin exposition or in patients suffering from severe pneumonia or sepsis. sTREM-1 can be measured in biological fluids and may be useful as a diagnostic tool. The monoclonal antibody 6B1 recognizes both membrane bound and soluble TREM-1. Also, the monoclonal antibody 6B1 neutralizes the interaction between TREM-1 and its ligand. TREM-1, triggering receptor expressed on myeloid cells 1, TREM1 Aliases Recombinant TREM-1 - IgG1 fusion protein. Immunogen Mouse IgG1